Population-based studies in North American patients, with breast cancer subtypes classified mostly by Immunohistochemistry (IHC) surrogate markers, have reported that Hispanic/Latina women are more likely to present with estrogen receptor negative (ER-) tumors, compared to non-Hispanic White (NHW) women [6, 26]. The gene discussed is ESR1; the disease is breast cancer.